Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Durvalumab's trials
NeoCOAST-2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Durvalumab
Ongoing
Recruiting
Phase 2
Open NCT05061550 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
